Short description
Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.
Description
Kannalife, a subsidiary of Neuropathix, Inc (OTCQB: NPTX), is a biopharmaceutical company focused on discovering, developing, and commercializing a product platform of novel molecules from our proprietary next-generation cannabinoid therapeutics as potent, non-opioid alternatives to treat patients with a variety of unmet medical needs.
Total funding
$$2020202
Sign in for full access
Location
Doylestown, Pennsylvania, United States, North America
Founded on
August 10, 2010
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Uh Ohhhh, Uh Ohhhh, Noaccessforu
Sign in for full access
Founders
Dean Petkanas, Thoma Kikis